91³Ô¹Ï

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
91³Ô¹Ï

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2091

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Validation of plasma proteasome as a tumor biomarker for diagnosis of hepatocellular carcinoma

6th Global Gastroenterologists Meeting

Shahira El-Etreby, Ahmed zaid, Monir Bahgat, Salah Al-Gamal, ManalAbd Elhamid, SherinAbd El-Azi, Hosam Zaghloul, Metwally Mortada, Mohamed El-Rakhawy and Gehan Mazroa

Mansoura University, Egypt

ScientificTracks Abstracts: J Gastrointest Dig Syst

DOI:

Abstract
Background & Aim: Early diagnosis of Hepatocellular Carcinoma (HCC) improves prognosis. While many studies revealed that alpha-fetoprotein (AFP) is a poor HCC biomarker, more recent studies nominated Plasma Proteasome (PP) as a promising one. So, our aim is to evaluate diagnostic accuracy of PP level as a tumor biomarker for diagnosis of early HCC in Egyptian patients with liver cirrhosis and to validate it on a large population. Methods: This study enrolled 120 patients with hepatitis C virus related cirrhosis (60 with HCC and 60 without HCC) versus 60 healthy controls. HCC patients were subdivided into 3 groups according to tumor burden. PP level and AFP were assessed. Then, validation of these results on large number of HCC population (308 cases) was done. Results: It was observed that, 200 ng/ml of AFP showed sensitivity for only 40.1%. On the other hand, AUC of PP was 0.883 (0.829-0.938), with cutoff value of 1.1 �¼g/ml having sensitivity of 98.3%, and specificity of 71.25%. There was no statistically significant correlation between the level of PP and tumor size, portal invasion or tumor stage (p values = 0.89, 0.07, and 0.82, respectively). Validation of these results on 308 patients yielded sensitivity of 95.12% and specificity of 60%. Conclusions: PP level could be a promising biomarker for early HCC diagnosis in cirrhotic patients.
Biography

Shahira El-Etreby has done her specialization in Internal Medicine in the year 2006. Currently, she is an Assistant Professor in Hepatology and Gastroenterology, Mansoura University, Egypt.

Email: monirbahgat@gmail.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top